B Ricciardelli

Summary

Publications

  1. ncbi request reprint Thrombocytopenia and purpura-like lesions associated with clopidogrel
    C Briguori
    Laboratory of Interventional Cardiology, Department of Cardiology, Clinica Mediterranea, Via Orazio, 2, 80121 Napoli
    Ital Heart J 2:935-7. 2001
  2. ncbi request reprint Acetylcysteine and contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    J Am Coll Cardiol 40:298-303. 2002
  3. ncbi request reprint Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, University of Milan, Milan, Italy
    Eur Heart J 25:206-11. 2004
  4. ncbi request reprint N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    J Am Coll Cardiol 44:762-5. 2004
  5. ncbi request reprint Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Kidney Int 68:2250-5. 2005
  6. ncbi request reprint Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Via Orazio, 2, I 80121, Naples, Italy
    Circulation 115:1211-7. 2007
  7. ncbi request reprint Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    Eur Heart J 25:1822-8. 2004
  8. ncbi request reprint Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Catheter Cardiovasc Interv 67:175-80. 2006

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Thrombocytopenia and purpura-like lesions associated with clopidogrel
    C Briguori
    Laboratory of Interventional Cardiology, Department of Cardiology, Clinica Mediterranea, Via Orazio, 2, 80121 Napoli
    Ital Heart J 2:935-7. 2001
    ..To our knowledge, this is the first case of thrombocytopenia associated with purpura-like lesions with no evidence of thrombotic thrombocytopenic purpura during clopidogrel treatment...
  2. ncbi request reprint Acetylcysteine and contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    J Am Coll Cardiol 40:298-303. 2002
    ..Prophylactic acetylcysteine along with hydration seems to be better than hydration alone in preventing the reduction in renal function induced by a contrast dye...
  3. ncbi request reprint Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, University of Milan, Milan, Italy
    Eur Heart J 25:206-11. 2004
    ..We tested whether a double dose of NAC is more effective to prevent CAN...
  4. ncbi request reprint N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    J Am Coll Cardiol 44:762-5. 2004
    ..We performed a study to assess the efficacy of fenoldopam mesylate (a specific agonist of the dopamine-1 receptor) as compared with N-acetylcysteine (NAC) in preventing contrast agent-associated nephrotoxicity (CAN)...
  5. ncbi request reprint Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Kidney Int 68:2250-5. 2005
    ..We evaluated the nephrotoxicity of iso- and low-osmolality contrast agents with prophylactic administration of N-acetylcysteine (NAC) along with hydration...
  6. ncbi request reprint Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies
    Carlo Briguori
    Laboratory of Interventional Cardiology, Clinica Mediterranea, Via Orazio, 2, I 80121, Naples, Italy
    Circulation 115:1211-7. 2007
    ..Preliminary data support the concept that sodium bicarbonate and ascorbic acid also may be effective in preventing CIN...
  7. ncbi request reprint Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Via Orazio 2, I 80121 Naples, Italy
    Eur Heart J 25:1822-8. 2004
    ..Peri-procedural non-Q-wave myocardial infarction is a frequent and prognostically important complication of percutaneous coronary intervention (PCI). It has been postulated that statins may reduce the rate of myocardial injury after PCI...
  8. ncbi request reprint Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures
    Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    Catheter Cardiovasc Interv 67:175-80. 2006
    ..We tested whether gadolinium-based contrast agent is less nephrotoxic than iodinated-contrast media...